Home Biosimilar Antibodies Apoptosis PD-1/PD-L1 antibody Garivulimab (Anti-B7-H1 / PD-L1 / CD274) For research use only.
Not for use in humans.

Garivulimab (Anti-B7-H1 / PD-L1 / CD274)

Synonyms: BGB-A333

Garivulimab (Anti-B7-H1 / PD-L1 / CD274) is a humanized immunoglobulin G1 (IgG1)-variant monoclonal antibody directed against the immunosuppressive ligand programmed cell death-1 ligand 1 (PD-L1; cluster of differentiation 274; CD274), with potential immune checkpoint inhibitory and antineoplastic activities. MW: 144.3 KD.

Garivulimab (Anti-B7-H1 / PD-L1 / CD274)

Purity & Quality Control

≥99

Choose Selective PD-1/PD-L1 Inhibitors

Biological Activity

Description Garivulimab (Anti-B7-H1 / PD-L1 / CD274) is a humanized immunoglobulin G1 (IgG1)-variant monoclonal antibody directed against the immunosuppressive ligand programmed cell death-1 ligand 1 (PD-L1; cluster of differentiation 274; CD274), with potential immune checkpoint inhibitory and antineoplastic activities. MW: 144.3 KD.

Product Details

CAS No. 2342597-81-1
Molecular Weight 144.3
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Garivulimab (Anti-B7-H1 / PD-L1 / CD274) | Garivulimab (Anti-B7-H1 / PD-L1 / CD274) supplier | purchase Garivulimab (Anti-B7-H1 / PD-L1 / CD274) | Garivulimab (Anti-B7-H1 / PD-L1 / CD274) cost | Garivulimab (Anti-B7-H1 / PD-L1 / CD274) manufacturer | order Garivulimab (Anti-B7-H1 / PD-L1 / CD274) | Garivulimab (Anti-B7-H1 / PD-L1 / CD274) distributor